info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

MicroRNA Market Research Report Information By Products & Services (Instruments, Consumables), By Application (Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Others), By End-Use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Others), –Market Forecast Till 2032


ID: MRFR/HC/20251-HCR | 128 Pages | Author: Rahul Gotadki| November 2024

MicroRNA Market Segmentation Tab


MicroRNA Products & Services Outlook (USD Billion, 2019-2032)




  • Instruments




  • Consumables




MicroRNA Application Outlook (USD Billion, 2019-2032)




  • Cancer




  • Infectious Diseases




  • Immunological Disorder




  • Cardiovascular Disease




  • Neurological Disease




  • Others




MicroRNA End-Use Outlook (USD Billion, 2019-2032)




  • Biotechnology & Pharmaceutical Companies




  • Academic & Government Research Institutes




  • Others




MicroRNA Regional Outlook (USD Billion, 2019-2032)




  • North America Outlook (USD Billion, 2019-2032)




    • North America MicroRNA by Products & Services




      • Instruments




      • Consumables






    • North America MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • North America MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others






    • US Outlook (USD Billion, 2019-2032)




    • US MicroRNA by Products & Services




      • Instruments




      • Consumables






    • US MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • US MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others






    • CANADA Outlook (USD Billion, 2019-2032)




    • CANADA MicroRNA by Products & Services




      • Instruments




      • Consumables






    • CANADA MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • CANADA MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others








  • Europe Outlook (USD Billion, 2019-2032)




    • Europe MicroRNA by Products & Services




      • Instruments




      • Consumables






    • Europe MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • Europe MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others






    • Germany Outlook (USD Billion, 2019-2032)




    • Germany MicroRNA by Products & Services




      • Instruments




      • Consumables






    • Germany MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • Germany MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others






    • France Outlook (USD Billion, 2019-2032)




    • France MicroRNA by Products & Services




      • Instruments




      • Consumables






    • France MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • France MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others






    • UK Outlook (USD Billion, 2019-2032)




    • UK MicroRNA by Products & Services




      • Instruments




      • Consumables






    • UK MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • UK MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others






    • ITALY Outlook (USD Billion, 2019-2032)




    • ITALY MicroRNA by Products & Services




      • Instruments




      • Consumables






    • ITALY MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • ITALY MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others






    • SPAIN Outlook (USD Billion, 2019-2032)




    • Spain MicroRNA by Products & Services




      • Instruments




      • Consumables






    • Spain MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • Spain MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others






    • Rest Of Europe Outlook (USD Billion, 2019-2032)




    • Rest Of Europe MicroRNA by Products & Services




      • Instruments




      • Consumables






    • REST OF EUROPE MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • REST OF EUROPE MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others








  • Asia-Pacific Outlook (USD Billion, 2019-2032)




    • Asia-Pacific MicroRNA by Products & Services




      • Instruments




      • Consumables






    • Asia-Pacific MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • Asia-Pacific MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others






    • China Outlook (USD Billion, 2019-2032)




    • China MicroRNA by Products & Services




      • Instruments




      • Consumables






    • China MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • China MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others






    • Japan Outlook (USD Billion, 2019-2032)




    • Japan MicroRNA by Products & Services




      • Instruments




      • Consumables






    • Japan MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • Japan MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others






    • India Outlook (USD Billion, 2019-2032)




    • India MicroRNA by Products & Services




      • Instruments




      • Consumables






    • India MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • India MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others






    • Australia Outlook (USD Billion, 2019-2032)




    • Australia MicroRNA by Products & Services




      • Instruments




      • Consumables






    • Australia MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • Australia MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others






    • Rest of Asia-Pacific Outlook (USD Billion, 2019-2032)




    • Rest of Asia-Pacific MicroRNA by Products & Services




      • Instruments




      • Consumables






    • Rest of Asia-Pacific MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • Rest of Asia-Pacific MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others








  • Rest of the World Outlook (USD Billion, 2019-2032)




    • Rest of the World MicroRNA by Products & Services




      • Instruments




      • Consumables






    • Rest of the World MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • Rest of the World MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others






    • Middle East Outlook (USD Billion, 2019-2032)




    • Middle East MicroRNA by Products & Services




      • Application Security




      • Network Security




      • Data Security




      • Endpoint Security






    • Middle East MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • Middle East MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others






    • Africa Outlook (USD Billion, 2019-2032)




    • Africa MicroRNA by Products & Services




      • Instruments




      • Consumables






    • Africa MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • Africa MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others






    • Latin America Outlook (USD Billion, 2019-2032)




    • Latin America MicroRNA by Products & Services




      • Instruments




      • Consumables






    • Latin America MicroRNA by Application




      • Cancer




      • Infectious Diseases




      • Immunological Disorder




      • Cardiovascular Disease




      • Neurological Disease




      • Others






    • Latin America MicroRNA by End-Use




      • Biotechnology & Pharmaceutical Companies




      • Academic & Government Research Institutes




      • Others







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3.Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2.Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL MICRORNA MARKET, BY PRODUCTS & SERVICES

6.1. Overview

6.2. Instruments

6.3. Consumables

7. GLOBAL MICRORNA MARKET, BY APPLICATION

7.1. Overview

7.2. Cancer

7.3. Infectious Diseases

7.4. Immunological Disorder

7.5. Cardiovascular Disease

7.6. Neurological Disease

7.7. Others

8. GLOBAL MICRORNA MARKET, BY END-USE

8.1. Overview

8.2. Biotechnology & Pharmaceutical Companies

8.3. Academic & Government Research Institutes

8.4. Others

9. GLOBAL MICRORNA MARKET, BY REGION

9.1. Overview

9.1. North America

9.1.1. US

9.1.2. Canada

9.2. Europe

9.2.1. Germany

9.2.2. France

9.2.3. UK

9.2.4. Italy

9.2.5. Spain

9.2.6. Rest of Europe

9.3. Asia-Pacific

9.3.1. China

9.3.2. India

9.3.3. Japan

9.3.4. South Korea

9.3.5. Australia

9.3.6. Rest of Asia-Pacific

9.4. Rest of the World

9.4.1. Middle East

9.4.2. Africa

9.4.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global MicroRNA Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global MicroRNA Market,

10.7. Key developments and Growth Strategies

10.7.1. New Product Launch/Service Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2023

10.8.2. Major Players R&D Expenditure. 2023

11. COMPANY PROFILES

11.1. Qiagen

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Products Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Thermo Fisher Scientific

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Products Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Merck KGaA

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Products Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. NanoString Technologies

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Products Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Exiqon

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Products Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Illumina, Inc.

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Products Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Agilent Technologies

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Products Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Bio-Rad Laboratories, Inc.

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Products Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. New England Biolabs

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Products Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Roche Diagnostics

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Products Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL MICRORNA MARKET, SYNOPSIS, 2019-2032

TABLE 2 GLOBAL MICRORNA MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)

TABLE 3 GLOBAL MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 4 GLOBAL MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 5 GLOBAL MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 6 NORTH AMERICA: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 7 NORTH AMERICA: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 8 NORTH AMERICA: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 9 US: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 10 US: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 11 US: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 12 CANADA: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 13 CANADA: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 14 CANADA: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 1 EUROPE: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 2 EUROPE: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 3 EUROPE: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 4 GERMANY: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 5 GERMANY: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 6 GERMANY: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 7 FRANCE: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 8 FRANCE: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 9 FRANCE: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 10 ITALY: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 11 ITALY: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 12 ITALY: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 13 SPAIN: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 14 SPAIN: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 15 SPAIN: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 16 UK: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 17 UK: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 18 UK: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 19 REST OF EUROPE: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 20 REST OF EUROPE: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 21 REST OF EUROPE: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 22 ASIA-PACIFIC: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 23 ASIA-PACIFIC: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 24 ASIA-PACIFIC: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 25 JAPAN: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 26 JAPAN: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 27 JAPAN: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 28 CHINA: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 29 CHINA: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 30 CHINA: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 31 INDIA: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 32 INDIA: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 33 INDIA: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 34 AUSTRALIA: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 35 AUSTRALIA: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 36 AUSTRALIA: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 37 SOUTH KOREA: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 38 SOUTH KOREA: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 39 SOUTH KOREA: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 40 REST OF ASIA-PACIFIC: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 41 REST OF ASIA-PACIFIC: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 42 REST OF ASIA-PACIFIC: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 43 REST OF THE WORLD: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 44 REST OF THE WORLD: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 45 REST OF THE WORLD: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 46 MIDDLE EAST: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 47 MIDDLE EAST: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 48 MIDDLE EAST: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 49 AFRICA: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 50 AFRICA: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 51 AFRICA: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 52 LATIN AMERICA: MICRORNA MARKET, BY PRODUCTS & SERVICES, 2019-2032 (USD BILLION)

TABLE 53 LATIN AMERICA: MICRORNA MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 54 LATIN AMERICA: MICRORNA MARKET, BY END-USE, 2019-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL MICRORNA MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL MICRORNA MARKET

FIGURE 4 GLOBAL MICRORNA MARKET, SHARE (%), BY PRODUCTS & SERVICES, 2023

FIGURE 5 GLOBAL MICRORNA MARKET, SHARE (%), BY APPLICATION, 2023

FIGURE 6 GLOBAL MICRORNA MARKET, SHARE (%), BY END-USE, 2023

FIGURE 7 GLOBAL MICRORNA MARKET, SHARE (%), BY REGION, 2023

FIGURE 8 NORTH AMERICA: MICRORNA MARKET, SHARE (%), BY REGION, 2023

FIGURE 9 EUROPE: MICRORNA MARKET, SHARE (%), BY REGION, 2023

FIGURE 10 ASIA-PACIFIC: MICRORNA MARKET, SHARE (%), BY REGION, 2023

FIGURE 11 REST OF THE WORLD: MICRORNA MARKET, SHARE (%), BY REGION, 2023

FIGURE 12 GLOBAL MICRORNA MARKET: COMPANY SHARE ANALYSIS, 2023 (%)

FIGURE 13 QIAGEN: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 QIAGEN: SWOT ANALYSIS

FIGURE 15 THERMO FISHER SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS

FIGURE 17 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 MERCK KGAA: SWOT ANALYSIS

FIGURE 19 NANOSTRING TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 NANOSTRING TECHNOLOGIES: SWOT ANALYSIS

FIGURE 21 EXIQON: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 EXIQON: SWOT ANALYSIS

FIGURE 23 ILLUMINA, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 ILLUMINA, INC.: SWOT ANALYSIS

FIGURE 25 AGILENT TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 AGILENT TECHNOLOGIES: SWOT ANALYSIS

FIGURE 27 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS

FIGURE 29 NEW ENGLAND BIOLABS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 NEW ENGLAND BIOLABS: SWOT ANALYSIS

FIGURE 31 ROCHE DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 ROCHE DIAGNOSTICS: SWOT ANALYSIS

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.